According to CEO Tetiana Aleksandrova, Subsense’s noninvasive nanoparticle system could transform neural treatment methods. By combining neural reading with stimulation—bypassing traditional surgery—this technology shows promise in mitigating conditions like Parkinson’s. As detailed by Eleanor Garth on longevity.technology (April 2025), it paves the way for integrated, safer digital health and neurotechnology applications.